Jane Street Group, LLC Immuno Gen, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $3.53 Million - $8.49 Million	-283,411 Reduced 30.88%	634,353 $18.8 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $536,321 - $756,331	38,064 Added 4.33%	917,764 $14.6 Million
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $3.24 Million - $17.3 Million	863,069 Added 5189.52%	879,700 $16.6 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $191,779 - $257,099	-52,256 Reduced 75.86%	16,631 $63,000
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $185,972 - $257,908	40,873 Added 145.9%	68,887 $341,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $34,357 - $49,618	-7,669 Reduced 21.49%	28,014 $134,000
Q2 2022 Aug 16, 2022	SELL	$3.15 - $5.76 $366,660 - $670,464	-116,400 Reduced 76.54%	35,683 $161,000
Q1 2022 May 17, 2022	BUY	$4.26 - $7.48 $375,540 - $659,399	88,155 Added 137.9%	152,083 $724,000
Q4 2021 Feb 15, 2022	BUY	$4.75 - $7.5 $174,044 - $274,807	36,641 Added 134.28%	63,928 $475,000
Q3 2021 Nov 16, 2021	SELL	$5.02 - $6.59 $37,378 - $49,069	-7,446 Reduced 21.44%	27,287 $155,000
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $65,751 - $97,661	11,356 Added 48.58%	34,733 $229,000
Q1 2021 May 18, 2021	SELL	$6.5 - $10.53 $489,456 - $792,919	-75,301 Reduced 76.31%	23,377 $189,000
Q4 2020 Feb 17, 2021	BUY	$3.7 - $7.66 $49,013 - $101,472	13,247 Added 15.51%	98,678 $637,000
Q3 2020 Nov 17, 2020	BUY	$3.45 - $4.89 $127,736 - $181,052	37,025 Added 76.49%	85,431 $307,000
Q2 2020 Aug 17, 2020	BUY	$3.32 - $5.34 $160,707 - $258,488	48,406 New	48,406 $223,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $30,489 - $78,595	-13,551 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $492,926 - $752,712	-222,039 Reduced 94.25%	13,551 $33,000
Q2 2019 Aug 15, 2019	BUY	$1.8 - $3.3 $424,062 - $777,447	235,590 New	235,590 $511,000
Q1 2019 May 16, 2019	SELL	$2.41 - $5.91 $170,461 - $418,020	-70,731 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$3.94 - $9.7 $227,988 - $561,290	57,865 Added 449.75%	70,731 $340,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $11,420 - $14,953	-1,328 Reduced 9.36%	12,866 $122,000
Q2 2018 Aug 15, 2018	SELL	$9.52 - $12.15 $148,216 - $189,163	-15,569 Reduced 52.31%	14,194 $138,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $87,341 - $168,816	-13,036 Reduced 30.46%	29,763 $313,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $231,114 - $362,507	42,799	42,799 $327,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account